Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced a significant milestone for its flagship Oncotype DX Breast Recurrence Score® test: ...

SAN ANTONIO – An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR ...

New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...

“Realized through collaboration between ECOG-ACRIN, NCI, and Caris Life Sciences, this public-private partnership represents a methodological, logistical, and collaborative integration of datasets ...

A new risk score can help predict whether a pancreatic cancer survivor will suffer a recurrence of cancer The 13-point risk score can help doctors more closely monitor patients at higher risk About 10 ...

Add Yahoo as a preferred source to see more of our stories on Google. The new risk score could help better manage the follow-up care for patients who've had pancreatic tumors surgically removed, and ...